Sign In
Buy DXCM
$82.66
-4.28 (-4.92%)
At Close: Aug 05, 2026
2 Growth Stocks That Are Soaring: Are They Buys?
08:45am, Saturday, 05'th Nov 2022
Both companies are still down over the past year, but they were on fire in October.
Is It Too Late to Buy DexCom Stock?
08:45am, Friday, 04'th Nov 2022
The shares have been surging after the medical device specialist released its latest earnings report.
Is DexCom a Good Healthcare Stock to Buy Now?
05:31am, Wednesday, 02'nd Nov 2022
After rising about 50% in October, investors want to know if this stock still has any fuel in the tank.
7 Stocks Billionaires are Buying Now
06:46am, Tuesday, 01'st Nov 2022
It isn't easy to figure out which stocks billionaires are buying right now. With sky-high inflation, fears of recession, weak economic growth, Russia's invasion of Ukraine, and a weaker consumer, the
Glucose monitoring device maker DexCom stock rallies more than 50% in October to pace the S&P 500
11:57am, Monday, 31'st Oct 2022
keep them on track to be the S&P 500's SPX, -0.55% best October performer with a month-to-date gain of 50.6%. The rally comes as maker of glucose monitoring systems reported last week third-quarter re
DexCom Stock: Bull vs. Bear
09:02am, Sunday, 30'th Oct 2022
The diabetes care technology leader has a huge opportunity. But its valuation could be an issue.
DexCom (DXCM) Q3 Earnings Beat Estimates, Guidance Revised
02:18pm, Friday, 28'th Oct 2022
DexCom's (DXCM) third-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
Dexcom Stock Soars on Earnings and Revenue Beat
12:59pm, Friday, 28'th Oct 2022
The maker of glucose monitoring systems beats third-quarter earnings and revenue expectations.
DexCom (DXCM) Q3 Earnings and Revenues Surpass Estimates
07:33pm, Thursday, 27'th Oct 2022
DexCom (DXCM) delivered earnings and revenue surprises of 16.67% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
DexCom, Inc. (DXCM) Q3 2022 Earnings Call Transcript
07:28pm, Thursday, 27'th Oct 2022
DexCom, Inc. (NASDAQ:DXCM ) Q3 2022 Earnings Conference Call October 27, 2022 4:30 PM ET Company Participants Sean Christensen - IR Kevin Sayer - Chairman, President and CEO Jereme Sylvain - CFO Jake
Should You Buy Dexcom (DXCM) Ahead of Earnings?
12:48pm, Wednesday, 26'th Oct 2022
Dexcom (DXCM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
09:07am, Friday, 21'st Oct 2022
Don't overlook these top growth stocks trading at a discount.
Is a Beat Likely for DexCom (DXCM) This Earnings Season?
03:48pm, Thursday, 20'th Oct 2022
DexCom's (DXCM) third-quarter results are likely to reflect rising global awareness of its real-time CGM.
Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy
06:30am, Wednesday, 19'th Oct 2022
DexCom's latest products could drive lasting growth.
DexCom (DXCM) Soars 7.3%: Is Further Upside Left in the Stock?
09:47am, Monday, 10'th Oct 2022
DexCom (DXCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road
